Log In
Print
BCIQ
Print
Print this Print this
 

topsalysin (PORxin) (PRX302) (formerly PSA-PAH1)

  Manage Alerts
Collapse Summary General Information
Company Sophiris Bio Inc.
DescriptionRecombinant proaerolysin protein activated by prostate-specific antigen (PSA)
Molecular Target Glycophosphatidylinositol
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat benign prostatic hyperplasia (BPH)
Regulatory Designation

Partner

Kissei Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today